Virtus Lifesci Biotech Etf Fundamentals

BBP Etf  USD 59.52  1.04  1.78%   
Virtus LifeSci Biotech fundamentals help investors to digest information that contributes to Virtus LifeSci's financial success or failures. It also enables traders to predict the movement of Virtus Etf. The fundamental analysis module provides a way to measure Virtus LifeSci's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Virtus LifeSci etf.
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Virtus LifeSci Biotech ETF Beta Analysis

Virtus LifeSci's Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.





More About Beta | All Equity Analysis

Current Virtus LifeSci Beta

Most of Virtus LifeSci's fundamental indicators, such as Beta, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Virtus LifeSci Biotech is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, Beta is a measure of individual stock risk relative to the overall volatility of the stock market. and is calculated based on very sound finance theory - Capital Assets Pricing Model (CAPM).However, since Beta is calculated based on historical price movements it may not predict how a firm's stock is going to perform in the future.

In accordance with the recently published financial statements, Virtus LifeSci Biotech has a Beta of 0.7. This is much higher than that of the Virtus family and significantly higher than that of the Health category. The beta for all United States etfs is notably lower than that of the firm.

Virtus LifeSci Biotech Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Virtus LifeSci's current stock value. Our valuation model uses many indicators to compare Virtus LifeSci value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Virtus LifeSci competition to find correlations between indicators driving Virtus LifeSci's intrinsic value. More Info.
Virtus LifeSci Biotech is the top ETF in price to earning as compared to similar ETFs. It also is the top ETF in price to book as compared to similar ETFs fabricating about  0.09  of Price To Book per Price To Earning. The ratio of Price To Earning to Price To Book for Virtus LifeSci Biotech is roughly  10.86 . Comparative valuation analysis is a catch-all technique that is used if you cannot value Virtus LifeSci by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

Virtus Beta Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Virtus LifeSci's direct or indirect competition against its Beta to detect undervalued stocks with similar characteristics or determine the etfs which would be a good addition to a portfolio. Peer analysis of Virtus LifeSci could also be used in its relative valuation, which is a method of valuing Virtus LifeSci by comparing valuation metrics of similar companies.
Virtus LifeSci is currently under evaluation in beta as compared to similar ETFs.

Fund Asset Allocation for Virtus LifeSci

The fund consists of 98.73% investments in stocks, with the rest of investments allocated between various types of exotic instruments.
Asset allocation divides Virtus LifeSci's investment portfolio among different asset categories to balance risk and reward by investing in a diversified mix of instruments that align with the investor's goals, risk tolerance, and time horizon. Mutual funds, which pool money from multiple investors to buy a diversified portfolio of securities, use asset allocation strategies to manage the risk and return of their portfolios.
Mutual funds allocate their assets by investing in a diversified portfolio of securities, such as stocks, bonds, cryptocurrencies and cash. The specific mix of these securities is determined by the fund's investment objective and strategy. For example, a stock mutual fund may invest primarily in equities, while a bond mutual fund may invest mainly in fixed-income securities. The fund's manager, responsible for making investment decisions, will buy and sell securities in the fund's portfolio as market conditions and the fund's objectives change.
As returns on the market increase, Virtus LifeSci's returns are expected to increase less than the market. However, during the bear market, the loss of holding Virtus LifeSci is expected to be smaller as well.

Virtus Fundamentals

About Virtus LifeSci Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Virtus LifeSci Biotech's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Virtus LifeSci using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Virtus LifeSci Biotech based on its fundamental data. In general, a quantitative approach, as applied to this etf, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Under normal market conditions, the fund will invest not less than 80 percent of its assets in component securities of the index. Virtus Lifesci is traded on NYSEARCA Exchange in the United States.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

Additional Information and Resources on Investing in Virtus Etf

When determining whether Virtus LifeSci Biotech is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Virtus Etf is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Virtus Lifesci Biotech Etf. Highlighted below are key reports to facilitate an investment decision about Virtus Lifesci Biotech Etf:
Check out Virtus LifeSci Piotroski F Score and Virtus LifeSci Altman Z Score analysis.
You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
The market value of Virtus LifeSci Biotech is measured differently than its book value, which is the value of Virtus that is recorded on the company's balance sheet. Investors also form their own opinion of Virtus LifeSci's value that differs from its market value or its book value, called intrinsic value, which is Virtus LifeSci's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Virtus LifeSci's market value can be influenced by many factors that don't directly affect Virtus LifeSci's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Virtus LifeSci's value and its price as these two are different measures arrived at by different means. Investors typically determine if Virtus LifeSci is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Virtus LifeSci's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.